Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2014

01-06-2014 | Stanford Multidisciplinary Seminars

The Gates of Hell: Crohn’s Disease Isolated to the Pylorus and Ileo-Cecal Valve

Authors: Charumathi Raghu Subramanian, George Triadafilopoulos

Published in: Digestive Diseases and Sciences | Issue 6/2014

Login to get access

Excerpt

In 2006, a 24-year-old male of African-Caribbean ancestry was first evaluated with a 2-year history of low-grade fever, weight loss, decreased appetite, abdominal bloating and occasional, self-limited rectal bleeding. Moreover, he reported intermittent diffuse abdominal pain occurring before meals, relieved by eating, and at times awakening him at night. He was noted to have some mild epigastric and right lower quadrant tenderness and normal bowel sounds. An upper gastrointestinal series was reported as showing pyloric narrowing, an ulcerated duodenal bulb (Fig. 1a), and narrowing at the ileo-cecal junction without obstruction (Fig. 1b). An endoscopy confirmed the presence of severe pyloric stenosis without associated H. pylori gastritis; colonoscopy revealed ulceration of the ileo-cecal valve but otherwise normal colonic mucosa. Granulomata were not observed in pathologic specimens of pylorus and ileo-cecal valve. His past history was only significant for a positive tuberculin test in 1999 for which he had been treated with isoniazid. A secretin stimulation test performed in order to evaluate for the presence of a neuroendocrine tumor was negative. Serum antibodies associated with the presence of inflammatory bowel disease were not detected. He was diagnosed with Crohn’s disease based on these findings; treatment with rabeprazole 20 mg daily and azathioprine 100 mg daily transiently improved his symptoms.
Literature
1.
go back to reference Gottlieb C, Alpert S. Regional jejunitis. AJR. 1937;38:881–883. Gottlieb C, Alpert S. Regional jejunitis. AJR. 1937;38:881–883.
2.
go back to reference Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn’s disease. Virchows Arch. 1998;432:49–52.PubMedCrossRef Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn’s disease. Virchows Arch. 1998;432:49–52.PubMedCrossRef
3.
go back to reference Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn’s disease patients. Pathol Res Pract. 1985;179:377–387. Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn’s disease patients. Pathol Res Pract. 1985;179:377–387.
4.
go back to reference Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn’s disease of the upper gastrointestinal tract: a comparison with distal Crohn’s disease. Am J Gastroenterol. 1997;92:1467–1471.PubMed Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn’s disease of the upper gastrointestinal tract: a comparison with distal Crohn’s disease. Am J Gastroenterol. 1997;92:1467–1471.PubMed
6.
go back to reference Erkelens GW, van Deventer SJ. Endoscopic treatment of strictures in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2004;18:201–207.PubMedCrossRef Erkelens GW, van Deventer SJ. Endoscopic treatment of strictures in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2004;18:201–207.PubMedCrossRef
7.
go back to reference Wagtmans MJ, van Hogezand RA, Griffioen G, Verspaget HW, Lamers CB. Crohn’s disease of the upper gastrointestinal tract. Neth J Med. 1997;50:S2–S7.PubMedCrossRef Wagtmans MJ, van Hogezand RA, Griffioen G, Verspaget HW, Lamers CB. Crohn’s disease of the upper gastrointestinal tract. Neth J Med. 1997;50:S2–S7.PubMedCrossRef
8.
go back to reference van Hogezand RA, Witte AM, Veenendaal RA, Wagtmans MJ, Lamers CB. Proximal Crohn’s disease: review of the clinic-pathologic features and therapy. Inflamm Bowel Dis. 2001;7:328–337.PubMedCrossRef van Hogezand RA, Witte AM, Veenendaal RA, Wagtmans MJ, Lamers CB. Proximal Crohn’s disease: review of the clinic-pathologic features and therapy. Inflamm Bowel Dis. 2001;7:328–337.PubMedCrossRef
9.
go back to reference Miehsler W, Püspök A, Oberhuber T, Vogelsang H. Impact of different therapeutic regimens on the outcome of patients with Crohn’s disease of the upper gastrointestinal tract. Inflamm Bowel Dis. 2001;7:99–105.PubMedCrossRef Miehsler W, Püspök A, Oberhuber T, Vogelsang H. Impact of different therapeutic regimens on the outcome of patients with Crohn’s disease of the upper gastrointestinal tract. Inflamm Bowel Dis. 2001;7:99–105.PubMedCrossRef
10.
go back to reference Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Infliximab for Crohn’s disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol. 2001;96:722–729.PubMedCrossRef Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Infliximab for Crohn’s disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol. 2001;96:722–729.PubMedCrossRef
11.
12.
go back to reference Stienecker K, Gleichmann D, Neumayer U, Glaser HJ, Tonus C. Long-term results of endoscopic balloon dilatation of lower gastrointestinal tract strictures in Crohn’s disease: a prospective study. World J Gastroenterol. 2009;15:2623–2627.PubMedCentralPubMedCrossRef Stienecker K, Gleichmann D, Neumayer U, Glaser HJ, Tonus C. Long-term results of endoscopic balloon dilatation of lower gastrointestinal tract strictures in Crohn’s disease: a prospective study. World J Gastroenterol. 2009;15:2623–2627.PubMedCentralPubMedCrossRef
Metadata
Title
The Gates of Hell: Crohn’s Disease Isolated to the Pylorus and Ileo-Cecal Valve
Authors
Charumathi Raghu Subramanian
George Triadafilopoulos
Publication date
01-06-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3066-x

Other articles of this Issue 6/2014

Digestive Diseases and Sciences 6/2014 Go to the issue